BRPI1007884A2 - derivados de actagardina - Google Patents

derivados de actagardina

Info

Publication number: BRPI1007884A2
Authority: BR; Brazil
Prior art keywords: actagardine; derivatives; actagardine derivatives
Prior art date: 2009-02-04

Application number

BRPI1007884A

Other languages

English (en)

Inventor

Sjoerd Nicolaas Wadman

Original Assignee

Novacta Biosystems Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-02-04

Filing date

2010-02-02

Publication date

2016-09-06

2010-02-02 Application filed by Novacta Biosystems Ltd filed Critical Novacta Biosystems Ltd

2016-09-06 Publication of BRPI1007884A2 publication Critical patent/BRPI1007884A2/pt

Links

LAWKVNVCUPIOMG-HWWYPGLISA-N gardimycin Chemical class C1=CC=C2C(C[C@H](C(=O)NCC(=O)N[C@H](CO)C(=O)N[C@H](C)C(=O)NCC(=O)N[C@H](CC)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](C)C(=O)N[C@@H](C)C(=O)N[C@H](C)C(O)=O)C(C)C)NC(=O)[C@@H](NC(=O)[C@@H](C)NC(=O)[C@@H](CC)NC(=O)[C@@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@@H](CC)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](C)N)[C@@H](C)CC)C(C)C)=CNC2=C1 LAWKVNVCUPIOMG-HWWYPGLISA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/10—Peptides having 12 to 20 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Mycology (AREA)
Microbiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

BRPI1007884A 2009-02-04 2010-02-02 derivados de actagardina BRPI1007884A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US14985709P	2009-02-04	2009-02-04
PCT/GB2010/000188 WO2010089544A1 (en)	2009-02-04	2010-02-02	Actagardine derivatives

Publications (1)

Publication Number	Publication Date
BRPI1007884A2 true BRPI1007884A2 (pt)	2016-09-06

Family

ID=42112624

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI1007884A BRPI1007884A2 (pt)	2009-02-04	2010-02-02	derivados de actagardina

Country Status (15)

Country	Link
US (1)	US8729031B2 (pt)
EP (1)	EP2393829A1 (pt)
JP (1)	JP5731407B2 (pt)
KR (1)	KR20110122139A (pt)
CN (1)	CN102388060B (pt)
AU (1)	AU2010212183B2 (pt)
BR (1)	BRPI1007884A2 (pt)
CA (1)	CA2750883A1 (pt)
EA (1)	EA020733B1 (pt)
IL (1)	IL214327A0 (pt)
MX (1)	MX2011008043A (pt)
NZ (1)	NZ594675A (pt)
SG (1)	SG173504A1 (pt)
TW (1)	TWI504610B (pt)
WO (1)	WO2010089544A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0600928D0 (en)	2006-01-17	2006-02-22	Novacta Biosystems Ltd	Improvements relating to lantibiotics
GB0714029D0 (en)	2007-07-18	2007-08-29	Novacta Biosystems Ltd	Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en)	2007-07-18	2007-08-29	Novacta Biosystems Ltd	The use of type-B lantibiotic-based compounds having antimicrobial activity
NZ594011A (en)	2009-01-14	2013-12-20	Novacta Biosystems Ltd	Deoxyactagardine derivatives
TWI504610B (zh)	2009-02-04	2015-10-21	Novacta Biosystems Ltd	阿肽加定衍生物、其製備方法及其用途
CA2789164A1 (en) *	2010-02-02	2011-08-11	Novacta Biosystems Limited	Lantibiotic salts
GB201001688D0 (en)	2010-02-02	2010-03-17	Novacta Biosystems Ltd	Compounds
GB201013507D0 (en) *	2010-08-11	2010-09-22	Novacta Biosystems Ltd	Compounds
GB201013509D0 (en) *	2010-08-11	2010-09-22	Novacta Biosystems Ltd	Compounds
GB201013513D0 (en)	2010-08-11	2010-09-22	Novacta Biosystems Ltd	Formulations
GB201013508D0 (en) *	2010-08-11	2010-09-22	Novacta Biosystems Ltd	Compounds
US9745266B2 (en)	2013-04-01	2017-08-29	The Regents Of The University Of Colorado	Indoline alkaloid compounds

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3710795A (en)	1970-09-29	1973-01-16	Alza Corp	Drug-delivery device with stretched, rate-controlling membrane
US4746818A (en) *	1985-03-12	1988-05-24	Pitney Bowes Inc.	Circuit for maintaining the state of an output despite changes in the state of input
GB8507528D0 (en) *	1985-03-22	1985-05-01	Lepetit Spa	Basis monocarboxyamide derivatives
US5304540A (en)	1988-06-22	1994-04-19	Applied Microbiology, Inc.	Pharmaceutical bacteriocin compositions and methods for using the same
IN167138B (pt)	1988-08-17	1990-09-01	Hoechst India
GB8926639D0 (en)	1989-11-24	1990-01-17	Agricultural & Food Res	Delayed release formulations
KR0166088B1 (ko)	1990-01-23	1999-01-15	.	수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en)	1990-01-23	1994-12-27	University Of Kansas	Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
IT1260505B (it)	1992-06-01	1996-04-09	Poli Ind Chimica Spa	Sistemi farmaceutici orali a cessione ritardata per il rilascio specifico nel colon
IL107887A (en)	1992-12-08	2003-07-06	Ambi Inc	Stabilized lanthionine containing bacteriocin compositions
US5512269A (en)	1993-06-09	1996-04-30	Burroughs Wellcome, Co.	Method of treating retained pulmonary secretions
ATE255165T1 (de)	1994-09-12	2003-12-15	Aventis Pharma Gmbh	Rekombinantes mersacidin und verfahren zu seiner herstellung
AU713050B2 (en)	1995-06-23	1999-11-25	Ambi Inc.	A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection
GB9711643D0 (en)	1997-06-05	1997-07-30	Janssen Pharmaceutica Nv	Glass thermoplastic systems
US5985823A (en)	1997-06-09	1999-11-16	Ambi Inc.	Method for the treatment of diarrheal disease and for eliminating particular bacterial populations from the colon
US5958873A (en)	1997-06-09	1999-09-28	University Of Cincinnati	Oral formulation for treatment of bacteria-induced diseases of the colon
DE19745583A1 (de)	1997-10-15	1999-04-22	Hoechst Marion Roussel De Gmbh	Neues Lantibiotikum verwandt mit Actagardine, Verfahren zur Herstellung und Verwendung derselben
US6569830B1 (en)	1999-03-05	2003-05-27	Ambi, Inc.	Compositions and methods for treatment of staphylococcal infection while suppressing formation of antibiotic-resistant strains
NZ522783A (en)	2000-06-28	2004-07-30	Smithkline Beecham P	Wet milling process for pharmaceuticals with agitator or chamber having nylon with internal lubricant
GB0110432D0 (en)	2001-04-27	2001-06-20	Plant Bioscience Ltd	Lantibiotic production
WO2002103010A1 (en)	2001-06-14	2002-12-27	Plant Bioscience Limited	Methods and materials for targeted gene disruption in actinomycete bacteria
US7034113B2 (en) *	2002-02-22	2006-04-25	Paradigm Diagnostics, Llc	Bacteriocin-metal complexes in the detection of pathogens and other biological analytes
US6861236B2 (en)	2002-05-24	2005-03-01	Applied Nanosystems B.V.	Export and modification of (poly)peptides in the lantibiotic way
AU2003275129A1 (en)	2002-10-10	2004-05-04	Molichem Medicines, Inc.	Nucleic acids encoding duramycin
JP4163737B2 (ja)	2003-07-18	2008-10-08	ヴァイキュロンファーマシューティカルズ，インコーポレイテッド	抗生物質１０７８９１、そのａ１因子とａ２因子、その薬剤学的に許容される塩、組成物、およびその使用
US7351687B2 (en)	2003-07-18	2008-04-01	Vicuron Pharmaceuticals, Inc.	Antibiotic 107891, its factors A1 and A2, pharmaceutically acceptable salts and compositions, and use thereof
GB0406870D0 (en)	2004-03-26	2004-04-28	Novacta Biosystems Ltd	Improvements relating to the production of lantibiotics
CA2594151C (en) *	2004-12-07	2013-02-19	Applied Nanosystems B.V.	Methods for the production and secretion of modified peptides
JP2009509519A (ja)	2005-09-27	2009-03-12	ノヴァクタバイオシステムズリミティッド	ランチビオティックメルサシジンの変種およびそれらの使用
WO2007082112A2 (en) *	2006-01-06	2007-07-19	Faraday Technology, Inc.	Tin and tin alloy electroplating method with controlled internal stress and grain size of the resulting deposit
GB0600928D0 (en)	2006-01-17	2006-02-22	Novacta Biosystems Ltd	Improvements relating to lantibiotics
EP3594248B1 (en)	2006-10-27	2021-08-04	Capsugel Belgium NV	Hydroxypropyl methyl cellulose hard capsules and process of manufacture
US20110150917A1 (en)	2007-06-12	2011-06-23	The University Of British Columbia	Small Cationic Antimicrobial Peptides
GB0714029D0 (en)	2007-07-18	2007-08-29	Novacta Biosystems Ltd	Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en)	2007-07-18	2007-08-29	Novacta Biosystems Ltd	The use of type-B lantibiotic-based compounds having antimicrobial activity
MX2011005425A (es)	2008-11-24	2011-09-27	Sentinella Pharmaceuticals Inc Sentinella	Derivados de carboxiamida lantibiotica con actividad antibacteriana mejorada.
GB0900599D0 (en)	2009-01-14	2009-02-18	Novacta Biosystems Ltd	Treatment
NZ594011A (en)	2009-01-14	2013-12-20	Novacta Biosystems Ltd	Deoxyactagardine derivatives
TWI504610B (zh)	2009-02-04	2015-10-21	Novacta Biosystems Ltd	阿肽加定衍生物、其製備方法及其用途
EP2216937A1 (en)	2009-02-10	2010-08-11	Alcatel Lucent	Alarm notification between customer premises equipment and a remote management server

2010
- 2010-02-02 TW TW099103071A patent/TWI504610B/zh not_active IP Right Cessation
- 2010-02-02 SG SG2011055613A patent/SG173504A1/en unknown
- 2010-02-02 CA CA2750883A patent/CA2750883A1/en not_active Abandoned
- 2010-02-02 WO PCT/GB2010/000188 patent/WO2010089544A1/en not_active Ceased
- 2010-02-02 MX MX2011008043A patent/MX2011008043A/es active IP Right Grant
- 2010-02-02 US US13/147,805 patent/US8729031B2/en not_active Expired - Fee Related
- 2010-02-02 JP JP2011548763A patent/JP5731407B2/ja not_active Expired - Fee Related
- 2010-02-02 KR KR1020117019973A patent/KR20110122139A/ko not_active Withdrawn
- 2010-02-02 AU AU2010212183A patent/AU2010212183B2/en not_active Ceased
- 2010-02-02 BR BRPI1007884A patent/BRPI1007884A2/pt not_active IP Right Cessation
- 2010-02-02 EP EP10702536A patent/EP2393829A1/en not_active Withdrawn
- 2010-02-02 EA EA201190095A patent/EA020733B1/ru not_active IP Right Cessation
- 2010-02-02 NZ NZ594675A patent/NZ594675A/xx not_active IP Right Cessation
- 2010-02-02 CN CN201080016455.2A patent/CN102388060B/zh not_active Expired - Fee Related
2011
- 2011-07-28 IL IL214327A patent/IL214327A0/en unknown

Also Published As

Publication number	Publication date
EA020733B1 (ru)	2015-01-30
JP2012516883A (ja)	2012-07-26
TW201032817A (en)	2010-09-16
WO2010089544A1 (en)	2010-08-12
SG173504A1 (en)	2011-09-29
CN102388060B (zh)	2014-09-10
EP2393829A1 (en)	2011-12-14
NZ594675A (en)	2013-11-29
US8729031B2 (en)	2014-05-20
JP5731407B2 (ja)	2015-06-10
CA2750883A1 (en)	2010-08-12
TWI504610B (zh)	2015-10-21
AU2010212183A1 (en)	2011-08-18
IL214327A0 (en)	2011-09-27
EA201190095A1 (ru)	2012-02-28
CN102388060A (zh)	2012-03-21
KR20110122139A (ko)	2011-11-09
MX2011008043A (es)	2011-08-17
AU2010212183B2 (en)	2014-07-10
US20110294723A1 (en)	2011-12-01

Publication	Publication Date	Title
BRPI1013246A2 (pt)	2016-04-05	derivados de benzofuralina
BR112012002828A2 (pt)	2015-10-13	derivados de 5-fluorpirimidinona
DK2414015T3 (da)	2021-12-06	Laryngoskopsystem
DK2411442T4 (da)	2021-12-06	Umættet polyesterresin
DE112010004215A5 (de)	2012-08-23	Hydrostataktor
DE112010002949A5 (de)	2012-09-06	Kupplungstastpunkte
EP2433940A4 (en)	2012-10-10	SPIROIMIDAZOLONDERIVAT
DK2430035T3 (da)	2013-05-27	Uracylspipooxetannukleosider
BRPI1013844A2 (pt)	2016-04-12	derivados de piridina-isoxazol
EP2397480A4 (en)	2012-07-25	DIAZEPINEDIONEDERIVATE
BRPI1008827A2 (pt)	2016-02-23	deisobutenizador
BRPI1014968A2 (pt)	2016-12-13	subalargador
BRPI1007884A2 (pt)	2016-09-06	derivados de actagardina
DE112010002728A5 (de)	2012-06-21	Turboinhalator
BRPI1014454A2 (pt)	2016-04-05	derivados de isoxazol-pirazol
DE112010004249A5 (de)	2012-11-29	Spindelaktor
DE112009005323A5 (de)	2012-07-26	Hebelarmprüfmaschine
DE112009005462T8 (de)	2013-03-28	Lenkungsssteuervorrichtung
BRPI1008070A2 (pt)	2016-03-15	tricianoboratos
BR112012004964A2 (pt)	2016-04-05	girocóptero
BR112012002810A2 (pt)	2015-09-15	derivados de n1-acil-5-fluoropirimidinona
DK2483126T3 (da)	2015-06-22	Skinnekøretøj
EP2492266A4 (en)	2013-03-13	5-hydroxypyrimidine-4-carboxamide
FR2947857B1 (fr)	2012-03-30	Agencement de deshuileur
EP2401281A4 (en)	2012-08-15	PYRIMIDINPYRIMIDOINDAZOLDERIVAT

Legal Events

Date	Code	Title	Description
2017-01-17	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]	Free format text: REFERENTE A 7A ANUIDADE.
2017-05-23	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]